{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T08:33:39Z","timestamp":1648802019163},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.leukres.2008.06.015","type":"journal-article","created":{"date-parts":[[2008,7,22]],"date-time":"2008-07-22T09:00:49Z","timestamp":1216717249000},"page":"209-211","source":"Crossref","is-referenced-by-count":4,"title":["Do peripheral blasts count in myelodysplastic syndromes?"],"prefix":"10.1016","volume":"33","author":[{"given":"Canan","family":"Alhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresia M.","family":"Westers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert J.","family":"Ossenkoppele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjan A.","family":"van de Loosdrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.06.015_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.leukres.2008.06.015_bib2","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.015_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.leukres.2006.11.009","article-title":"Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference","volume":"31","author":"Valent","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2008.06.015_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.leukres.2007.04.020","article-title":"Flow cytometry in myelodysplastic syndromes: report from a working conference","volume":"32","author":"Loken","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2008.06.015_bib5","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.015_bib6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/sj.leu.2404564","article-title":"A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification","volume":"21","author":"Verburgh","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.06.015_bib7","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","article-title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes","volume":"25","author":"Malcovati","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2008.06.015_bib8","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1200\/JCO.2007.15.2926","article-title":"Time-dependent prognostic scoring system for myelodysplastic syndromes has significant limitations that may influence its reproducibility and practical application","volume":"26","author":"Bowen","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2008.06.015_bib9","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/sj.leu.2403963","article-title":"Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)","volume":"19","author":"Germing","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.06.015_bib10","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","article-title":"New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients","volume":"110","author":"Haase","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.015_bib11","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.leukres.2005.11.026","article-title":"Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome","volume":"30","author":"Font","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2008.06.015_bib12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2005-12-4916","article-title":"Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes","volume":"108","author":"Ogata","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.015_bib13","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2007-07-098764","article-title":"Identification of distinct prognostic subgroups in low and intermediate-1 risk myelodysplastic syndromes by flow cytometry","volume":"111","author":"van de Loosdrecht","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.015_bib14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.015_bib15","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.leukres.2008.03.028","article-title":"Prognostic value of circulating CD34+ cells in myelodysplastic syndromes","volume":"32","author":"Cesana","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2008.06.015_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.leukres.2007.02.021","article-title":"Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome","volume":"32","author":"Knipp","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2008.06.015_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0145-2126(99)00167-8","article-title":"Absolute number of circulating CD34+ cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t; novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry","volume":"24","author":"Fuchigami","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2008.06.015_bib18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ajh.2830390205","article-title":"Circulating CD34+ cells: an adverse prognostic factor in the myelodysplastic syndromes","volume":"39","author":"Sullivan","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2008.06.015_bib19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.exphem.2005.02.005","article-title":"Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia","volume":"33","author":"Timeus","year":"2005","journal-title":"Exp Hematol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608002920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608002920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T05:14:51Z","timestamp":1588828491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608002920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0145212608002920"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.06.015","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}